Severe Hyperkalemia Rare Despite Dual RAAS Blockade
Analysis of data from the HALT PKD trial showed that 0% to 0.4% of patients experienced potassium levels above 6.5 mEq/L.
Analysis of data from the HALT PKD trial showed that 0% to 0.4% of patients experienced potassium levels above 6.5 mEq/L.
Having hemoglobin 9-11 g/dL prior to dialysis provided the best life expectancy.
It is unclear whether RDW is a risk factor for early death or a byproduct of biological and metabolic imbalances.
Veteran patients with levels below 100 mg/dL had a 26% higher risk of mortality compared with patients with triglyceride levels of 150-200 mg/dL.
Study compared sucroferric oxyhydroxide and sevelamer carbonate.
Phosphate and vitamin D deficiency were linked with RLS severity.
Study finds no gender differences in parathyroid hormone, ferritin, Kt/V, or age.
Patients prescribed the lipid-lowering agents were less likely to exhibit hyporesponsiveness to the medications.
In a study, the mean hemoglobin level increased significantly in hemodialysis patients with functional iron deficiency.
It develops in 8% of patients overall and 15.1% of patients with stage 5 CKD.